Apolipoprotein E genotype, cardiovascular biomarkers and risk of stroke: systematic review and meta-analysis of 14,015 stroke cases and pooled analysis of primary biomarker data from up to 60,883 individuals.

BACKGROUND At the APOE gene, encoding apolipoprotein E, genotypes of the ε2/ε3/ε4 alleles associated with higher LDL-cholesterol (LDL-C) levels are also associated with higher coronary risk. However, the association of APOE genotype with other cardiovascular biomarkers and risk of ischaemic stroke is less clear. We evaluated the association of APOE genotype with risk of ischaemic stroke and assessed whether the observed effect was consistent with the effects of APOE genotype on LDL-C or other lipids and biomarkers of cardiovascular risk. METHODS We conducted a systematic review of published and unpublished studies reporting on APOE genotype and ischaemic stroke. We pooled 41 studies (with a total of 9027 cases and 61,730 controls) using a Bayesian meta-analysis to calculate the odds ratios (ORs) for ischaemic stroke with APOE genotype. To better evaluate potential mechanisms for any observed effect, we also conducted a pooled analysis of primary data using 16 studies (up to 60,883 individuals) of European ancestry. We evaluated the association of APOE genotype with lipids, other circulating biomarkers of cardiovascular risk and carotid intima-media thickness (C-IMT). RESULTS The ORs for association of APOE genotypes with ischaemic stroke were: 1.09 (95% credible intervals (CrI): 0.84-1.43) for ε2/ε2; 0.85 (95% CrI: 0.78-0.92) for ε2/ε3; 1.05 (95% CrI: 0.89-1.24) for ε2/ε4; 1.05 (95% CrI: 0.99-1.12) for ε3/ε4; and 1.12 (95% CrI: 0.94-1.33) for ε4/ε4 using the ε3/ε3 genotype as the reference group. A regression analysis that investigated the effect of LDL-C (using APOE as the instrument) on ischaemic stroke showed a positive dose-response association with an OR of 1.33 (95% CrI: 1.17, 1.52) per 1 mmol/l increase in LDL-C. In the separate pooled analysis, APOE genotype was linearly and positively associated with levels of LDL-C (P-trend: 2 × 10(-152)), apolipoprotein B (P-trend: 8.7 × 10(-06)) and C-IMT (P-trend: 0.001), and negatively and linearly associated with apolipoprotein E (P-trend: 6 × 10(-26)) and HDL-C (P-trend: 1.6 × 10(-12)). Associations with lipoprotein(a), C-reactive protein and triglycerides were non-linear. CONCLUSIONS In people of European ancestry, APOE genotype showed a positive dose-response association with LDL-C, C-IMT and ischaemic stroke. However, the association of APOE ε2/ε2 genotype with ischaemic stroke requires further investigation. This cross-domain concordance supports a causal role of LDL-C on ischaemic stroke.

[1]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[2]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[3]  M. Pirinen,et al.  Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke , 2012, Nature Genetics.

[4]  W. Rathmann,et al.  Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque , 2011, Nature Genetics.

[5]  M. Pencina,et al.  Carotid-wall intima-media thickness and cardiovascular events. , 2011, The New England journal of medicine.

[6]  J. Danesh,et al.  Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.

[7]  Tanya M. Teslovich,et al.  Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.

[8]  M. Pittler.  Systematic Reviews in Health Care: Meta‐analysis in Context , 2010 .

[9]  C. Sudlow,et al.  Genetic Effects on Carotid Intima-Media Thickness: Systematic Assessment and Meta-Analyses of Candidate Gene Polymorphisms Studied in More Than 5000 Subjects , 2010, Circulation. Cardiovascular genetics.

[10]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[11]  Tom R. Gaunt,et al.  Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. , 2009, American journal of human genetics.

[12]  R. Luben,et al.  APOE genotype, lipids, and coronary heart disease risk: a prospective population study. , 2009, Archives of internal medicine.

[13]  Ian J. Brown,et al.  Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. , 2009, JAMA.

[14]  L. Smeeth,et al.  Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk , 2009, Human molecular genetics.

[15]  Julian Little,et al.  Systematic Reviews of Genetic Association Studies , 2009, PLoS medicine.

[16]  I. Deary,et al.  Low dose aspirin and cognitive function in middle aged to elderly adults: randomised controlled trial , 2008, BMJ : British Medical Journal.

[17]  E. Boerwinkle,et al.  APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels. , 2008, Human molecular genetics.

[18]  R. Collins,et al.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.

[19]  Dolores Corella,et al.  Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans , 2008, Nature Genetics.

[20]  C. Sudlow,et al.  Association Between Apolipoprotein E Genotype and Carotid Intima-Media Thickness May Suggest a Specific Effect on Large Artery Atherothrombotic Stroke , 2008, Stroke.

[21]  D. Lawlor,et al.  Clustered Environments and Randomized Genes: A Fundamental Distinction between Conventional and Genetic Epidemiology , 2007, PLoS medicine.

[22]  P. Steg,et al.  The paradox of cholesterol and stroke , 2007, The Lancet.

[23]  R. Collins,et al.  Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths , 2007, The Lancet.

[24]  J. Stengård,et al.  Variation in 5' Promoter Region of the APOE gene Contributes to Predicting Ischemic Heart Disease (IHD) in the Population at Large: the Copenhagen City Heart Study , 2007, Annals of human genetics.

[25]  J. Danesh,et al.  Association of apolipoprotein E genotypes with lipid levels and coronary risk. , 2007, JAMA.

[26]  Elena Tremoli,et al.  Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. , 2007, European heart journal.

[27]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[28]  G. Siest,et al.  Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles , 2007, Genes and Immunity.

[29]  L. Lind,et al.  Apolipoprotein E ε4 Genotype is Independently Associated with Increased Intima-Media Thickness in a Recessive Pattern , 2007, Lipids.

[30]  Y. Ho,et al.  Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF-alpha and IL-6 in macrophages. , 2007, Archives of biochemistry and biophysics.

[31]  A. D. de Craen,et al.  Plasma Levels of Apolipoprotein E and Risk of Stroke in Old Age , 2007, Annals of the New York Academy of Sciences.

[32]  N. Salkind.  Encyclopedia of Measurement and Statistics , 2006 .

[33]  D. Lawlor,et al.  Integrated single-label liquid-phase assay of APOE codons 112 and 158 and a lipoprotein study in British women. , 2006, Clinical chemistry.

[34]  D. Lawlor,et al.  The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. , 2006, European heart journal.

[35]  D. Lawlor,et al.  Serum cholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction: Korean national health system prospective cohort study , 2006, BMJ : British Medical Journal.

[36]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[37]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[38]  P. Ridker,et al.  Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein , 2006, Genes and Immunity.

[39]  T. Lehtimäki,et al.  Apolipoprotein E genotype is related to plasma levels of C‐reactive protein and lipids and to longevity in nonagenarians , 2006, Clinical endocrinology.

[40]  C. Sudlow,et al.  Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. , 2006, Stroke.

[41]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[42]  Michael Marmot,et al.  Cohort Profile: the Whitehall II study. , 2005, International journal of epidemiology.

[43]  W. März,et al.  The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study). , 2004, European heart journal.

[44]  P. Whincup,et al.  The British Regional Heart Study 1975-2004. , 2004, International journal of epidemiology.

[45]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[46]  A. Smit,et al.  Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. , 2004, Circulation.

[47]  Julian P T Higgins,et al.  Controlling the risk of spurious findings from meta‐regression , 2004, Statistics in medicine.

[48]  S. Humphries,et al.  Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. , 2004, European heart journal.

[49]  S. Ebrahim,et al.  Mendelian randomization: prospects, potentials, and limitations. , 2004, International journal of epidemiology.

[50]  Guido Knapp,et al.  Improved tests for a random effects meta‐regression with a single covariate , 2003, Statistics in medicine.

[51]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[52]  J. Beilby,et al.  Apolipoprotein E Gene Polymorphisms Are Associated With Carotid Plaque Formation but Not With Intima-Media Wall Thickening: Results From the Perth Carotid Ultrasound Disease Assessment Study (CUDAS) , 2003, Stroke.

[53]  W. Jagust,et al.  Prevalence of Dementia in Older Latinos: The Influence of Type 2 Diabetes Mellitus, Stroke and Genetic Factors , 2003, Journal of the American Geriatrics Society.

[54]  D. Lawlor,et al.  Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study , 2003, Journal of epidemiology and community health.

[55]  V. Feigin,et al.  Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century , 2003, The Lancet Neurology.

[56]  Eric Boerwinkle,et al.  Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. , 2002, American journal of human genetics.

[57]  D. Spiegelhalter,et al.  Bayesian random effects meta‐analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales , 2002, Statistics in medicine.

[58]  D. Blazer,et al.  Apolipoprotein E ε4 and Risk of Mortality in African American and White Older Community Residents , 2002 .

[59]  A. Hofman,et al.  Apolipoprotein E and Carotid Artery Atherosclerosis: The Rotterdam Study , 2001, Stroke.

[60]  S. Humphries,et al.  Rapid determination of apolipoprotein E genotype using a heteroduplex generator. , 1999, Journal of lipid research.

[61]  M. Khoury,et al.  The Human Genome Epidemiology Network. , 1998, American journal of epidemiology.

[62]  J. Roitelman,et al.  Improved PCR amplification/Hhal restriction for unambiguous determination of apolipoprotein E alleles. , 1995, Clinical chemistry.

[63]  John Hardy,et al.  Single-day apolipoprotein E genotyping , 1994, Journal of Neuroscience Methods.

[64]  P. de Knijff,et al.  Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. , 1993, American journal of human genetics.

[65]  R. Prescott,et al.  Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. , 1991, International journal of epidemiology.

[66]  P. Talmud,et al.  Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects. , 1991, Journal of lipid research.

[67]  C. Rosenfeld,et al.  Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome. , 1990, American journal of obstetrics and gynecology.

[68]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[69]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[70]  F. Naeim,et al.  Letter: HL-A antigens in myasthenia gravis. , 1974, Lancet.

[71]  R. Collins,et al.  Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.

[72]  Christian Gieger,et al.  Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts , 2009, Nature Genetics.

[73]  T. Lehtimäki,et al.  Relation of apolipoprotein E polymorphism to markers of early atherosclerotic changes in young adults--the Cardiovascular Risk in Young Finns Study. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[74]  S. Cichon,et al.  Bmc Medical Genomics a Genome-wide Association Study for Late-onset Alzheimer's Disease Using Dna Pooling , 2008 .

[75]  H. Abdi.  The Bonferonni and Šidák Corrections for Multiple Comparisons , 2006 .

[76]  J. Nazroo.  Health, wealth and lifestyles of the older population in England: The 2002 English Longitudinal Study of Ageing , 2003 .

[77]  D. Blazer,et al.  Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents. , 2002, The Gerontologist.

[78]  Douglas G. Altman,et al.  Systematic Reviews in Health Care , 2001 .

[79]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[80]  E. Corder,et al.  Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study. , 2000, Stroke.

[81]  Peter Green,et al.  Markov chain Monte Carlo in Practice , 1996 .

[82]  J. Cooper,et al.  The Effects of Quality and Timing of Venepuncture on Markers of Blood Coagulation in Healthy Middle-aged Men , 1995, Thrombosis and Haemostasis.

[83]  F. Cambien,et al.  The European Atherosclerosis Research Study (EARS): design and objectives. , 1994, International journal of epidemiology.

[84]  Wolfgang Babisch,et al.  Traffic noise, work noise and cardiovascular risk factors : the Caerphilly and Speedwell collaborative heart disease studies , 1990 .

[85]  The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. , 1988, Journal of clinical epidemiology.

[86]  M. Kornitzer,et al.  The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease): A major international Collaboration , 1988 .

[87]  Mario Falchi,et al.  Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia , 2022 .